Caisse de depot et placement du Quebec
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 898286
Montreal, A8
Position in ALNY
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$657,769
-$19,860,175 QoQ
Shares Held
1,988
-96.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Caisse de depot et placement du Quebec holds $667,145,858 across 11 Biotechnology names. ALNY ranks #8 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
329,018 | $254,212,467 | |
| 2 | INCY |
Incyte Corp
|
1,520,486 | $143,108,142 | |
| 3 | EXEL |
Exelixis, Inc.
|
2,542,819 | $109,061,506 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,121,200 | $72,463,156 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
945,603 | $53,417,113 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
50,917 | $22,736,477 | |
| 7 | RPRX |
Royalty Pharma plc
|
218,031 | $10,458,947 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
1,988 | $657,769 |
All Filings in ALNY
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $657,769 | 1,988 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $20,517,944 | 51,598 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,128,656 | 17,826 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,536,147 | 20,044 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,416,485 | 23,763 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,357,335 | 10,018 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,956,883 | 25,295 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,146,685 | 25,295 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,705,612 | 24,795 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,750,678 | 19,595 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,251,118 | 12,711 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,414,327 | 12,711 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,984,768 | 14,900 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,540,985 | 14,900 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $261,654 | 1,794 | Shares | Sole | 2022-08-12 | |
| 2021-03-31 | $238,187 | 1,687 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $5,279,771 | 40,623 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $393,120 | 2,700 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $429,519 | 2,900 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $446,285 | 4,100 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||